PRESS RELEASE

 

BurnsAdler Pharmaceuticals, Inc. and Farmaceuticas Avanzadas, S.A. Execute Licensing Agreement for NeoVisc

 

Charlotte, North Carolina – (October 27, 2003) – BurnsAdler Pharmaceuticals, Inc. (“BurnsAdler”) announced today that it has entered into a long term promotional agreement with Farmaceuticas Avanzadas S.A. to market NeoVisc® in the Dominican Republic and Haiti.

Carolina Cortez, Director of BurnsAdler remarked, “Martin and his team have built an excellent company focused on promoting niche pharmaceuticals to orthopedists and rheumatologists.  We know they will do an excellent job helping make NeoVisc® the top performing viscosupplement in the Caribbean marketplace.  With the U.S. market for viscosupplements having grown to over $500 million annually, we believe a lower cost, high quality (non-cock’s comb) product will do very well in emerging viscosupplement markets such as the Dominican Republic and Haiti.”

Farmaceuticas Avanzadas, S.A. is a leading specialty pharmaceutical company headquartered in the Dominican Republic.

BurnsAdler is an internationally focused specialty pharmaceutical company that provides cost effective product distribution and promotion for select emerging pharmaceutical companies. BurnsAdler creates long term, exclusive agreements which grant it the right to license, supply and market products wherever their partners are interested in generating additional revenue and profit.  The Company focuses on promoting products in Europe, South America, Latin America, Far East, Canada and the Caribbean.

For additional information about this news release contact Carolina Cortez at +1.704.552-8410 Ext. 225.  Find additional information about BurnsAdler at www.burnsadler.com.